Cypt6 Inhibitors
Cypt6, or Cryptochrome-6, assumes a pivotal role in the complex regulatory network governing circadian rhythms. As a transcriptional repressor within the molecular clock machinery, Cypt6 forms complexes with other clock-related proteins to modulate the expression of target genes. Specifically, Cypt6 contributes to the precise temporal orchestration of various physiological processes in response to external environmental cues, particularly light.
Inhibition of Cypt6 involves disrupting its interactions within the circadian regulatory network. The identified chemical inhibitors impact various signaling pathways indirectly linked to Cypt6 function. For instance, SB216763 interferes with Wnt signaling, impacting downstream events that indirectly inhibit Cypt6 function within the cellular regulatory network. U0126, a MEK inhibitor, disrupts the MAPK pathway, affecting downstream elements that indirectly hinder Cypt6 function. Wortmannin, a PI3K inhibitor, modulates the PI3K-Akt pathway, altering events that indirectly inhibit Cypt6 and its interconnected signaling cascades. These inhibitors collectively provide a diverse set of tools for researchers to delve into the intricate molecular mechanisms governed by Cypt6. By understanding the specific points of intervention and the interconnected pathways involved, scientists can unravel the complexities of circadian rhythmicity and gain valuable insights into the temporal orchestration of physiological processes orchestrated by Cypt6.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, interferes with Wnt signaling, impacting downstream events that indirectly inhibit Cypt6 function within the cellular regulatory network. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, interferes with the PI3K-Akt pathway, indirectly modulating factors that affect Cypt6 expression and its associated cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, modulates the JNK pathway, influencing factors that indirectly inhibit Cypt6 and its involvement in cellular regulatory networks. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts the PI3K-Akt pathway, altering events that indirectly inhibit Cypt6 and its interconnected signaling cascades. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, interferes with the MAPK pathway, influencing downstream events that indirectly hinder Cypt6 function and its related cellular processes. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI, also called CHIR99021 modulates Wnt signaling, impacting downstream events that indirectly inhibit Cypt6 function within the cellular regulatory network. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42, also called AG-490, a JAK2 inhibitor, interferes with JAK-STAT signaling, modulating factors that indirectly hinder Cypt6 expression and its role in cellular regulatory networks. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin disrupts mTOR signaling, impacting cellular processes connected to Cypt6 expression, leading to an indirect inhibition of the target protein. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, modulates TGF-β signaling, influencing factors that indirectly inhibit Cypt6 and its involvement in cellular regulatory networks. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
GSK650394, a p38 MAPK inhibitor, modulates the p38 pathway, influencing factors that indirectly inhibit Cypt6 and its involvement in cellular regulatory networks. | ||||||